Clinical Trials Browser

Anemia, Breast Neoplasms, Leukemia, Lung Neoplasms, Lymphoma, Multiple Myeloma, Myeloproliferative Disorders, Precancerous Conditions, Neoplasms, Plasma Cell, Drug-Related Side Effects and Adverse Reactions

NCT00305643 2015-12-24

Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer

Phase 3 Terminated

11 enrolled 7 charts

BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms, Pain, Rectal Neoplasms, Colorectal Neoplasms, Breast Neoplasms, Male, Hand-Foot Syndrome, Drug-Related Side Effects and Adverse Reactions

NCT00245050 2011-12-30

Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer

Phase 3 Completed

34 enrolled 9 charts

BreastGynecologic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms, Breast Neoplasms, Male, Drug-Related Side Effects and Adverse Reactions

NCT00221702 2010-10-13

EADO

Phase 3 Completed

898 enrolled

Dermatologic

Melanoma, Neoplasm Metastasis, Drug-Related Side Effects and Adverse Reactions

Clinical Trials

05-001: Treatment of Acute Lymphoblastic Leukemia in Children

ASF-BC

Study Comparing Conventional and Fast Track Multi-Discipline Treatment Interventions for Colorectal Cancer

Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other Cancer

Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy

Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer

Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer

EADO